Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Research groups

Tristan Kennedy

PhD

Postdoctoral researcher

Research Summary

My research is focused on the role of chromosomal instability (CIN) in tumourigenesis. Specifically, I am investigating how two protocadherin proteins, FAT1 and FAT4 contribute to CIN in triple-negative breast cancer (TNBC). By identifying these roles, we hope to find novel treatment strategies.


Biography

Tristan completed his PhD in Cancer and Genomic Sciences at the University of Birmingham in 2023 as part of the MRC IMPACT doctoral training programme. During this doctoral work in the group of Professor Mathew Coleman, Tristan investigated the role of a novel hydroxylase enzyme complex in maintaining replication fidelity and genome stability. He subsequently undertook a short postdoctoral position within the Coleman group before joining the Department of Oncology to work with Dr Wei-Ting Lu in January 2026.